The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2023 | PET-guided treatment: the new standard of care in Hodgkin lymphoma?
Peter Borchmann, MD, University Hospital Cologne, Cologne, Germany, briefly comments on the use of PET-guided treatment in Hodgkin lymphoma (HL) and further discusses factors which may influence whether this becomes the new standard of care (SOC) in this disease. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
